Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.
Age
6–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children 6 - 12 with a diagnosis of ADHD of any type , Same teacher who is willing to complete the assessment during the school term
You may not be if
Previous cardiac problems of the patient or the parents or current cardiac findings of the patient; Relevant medical condition other than ADHD; ADHD medication within a specified timeperiod prior to study start; Pregnancy or nursing; Positive drug screen